Northern Trust’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$714K Sell
204,619
-3,453
-2% -$12.4K ﹤0.01% 3475
2025
Q4
$712K Sell
208,072
-9,956
-5% -$44.4K ﹤0.01% 3527
2025
Q3
$1.1M Buy
218,028
+142,246
+188% +$627K ﹤0.01% 3364
2025
Q2
$260K Buy
75,782
+714
+1% +$1.78K ﹤0.01% 3849
2025
Q1
$167K Sell
75,068
-6,553
-8% -$18.8K ﹤0.01% 3991
2024
Q4
$239K Buy
81,621
+42,174
+107% +$117K ﹤0.01% 3923
2024
Q3
$103K Sell
39,447
-935
-2% -$2.59K ﹤0.01% 4049
2024
Q2
$120K Sell
40,382
-7,309
-15% -$27.7K ﹤0.01% 4010
2024
Q1
$216K Sell
47,691
-8,786
-16% -$44.8K ﹤0.01% 3867
2023
Q4
$322K Buy
+56,477
New +$262K ﹤0.01% 3703
2023
Q3
Sell
-100,268
Closed -$648K 4461
2023
Q2
$648K Sell
100,268
-1,585,189
-94% -$10.8M ﹤0.01% 3481
2023
Q1
$12.7M Sell
1,685,457
-55,960
-3% -$508K ﹤0.01% 1863
2022
Q4
$17.6M Buy
1,741,417
+234,169
+16% +$2.71M ﹤0.01% 1619
2022
Q3
$14.9M Buy
1,507,248
+87,819
+6% +$964K ﹤0.01% 1696
2022
Q2
$15.1M Buy
+1,419,429
New +$12M ﹤0.01% 1729

Other funds holding ABCL